vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and WESTPORT FUEL SYSTEMS INC. (WPRT). Click either name above to swap in a different company.

Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $12.5M, roughly 1.5× WESTPORT FUEL SYSTEMS INC.). Apyx Medical Corp runs the higher net margin — -6.8% vs -274.8%, a 268.0% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -11.4%). Apyx Medical Corp produced more free cash flow last quarter ($-2.8M vs $-6.4M).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Westport Innovations is a company that develops alternative fuel, low-emissions technologies to allow engines to operate on clean-burning fuels such as compressed natural gas (CNG), liquefied natural gas (LNG), hydrogen and biofuels such as landfill gas. Headquartered in Vancouver, British Columbia, Canada, where the company was founded, Westport also has facilities in France, Sweden, Italy, China, Australia and the United States.

APYX vs WPRT — Head-to-Head

Bigger by revenue
APYX
APYX
1.5× larger
APYX
$19.2M
$12.5M
WPRT
Growing faster (revenue YoY)
APYX
APYX
+46.2% gap
APYX
34.7%
-11.4%
WPRT
Higher net margin
APYX
APYX
268.0% more per $
APYX
-6.8%
-274.8%
WPRT
More free cash flow
APYX
APYX
$3.6M more FCF
APYX
$-2.8M
$-6.4M
WPRT

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
APYX
APYX
WPRT
WPRT
Revenue
$19.2M
$12.5M
Net Profit
$-1.3M
$-34.3M
Gross Margin
62.6%
6.7%
Operating Margin
0.1%
-8.1%
Net Margin
-6.8%
-274.8%
Revenue YoY
34.7%
-11.4%
Net Profit YoY
71.9%
-690.4%
EPS (diluted)
$-1.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
WPRT
WPRT
Q4 25
$19.2M
Q3 25
$12.9M
Q2 25
$11.4M
$12.5M
Q1 25
$9.4M
Q4 24
$14.2M
Q3 24
$11.5M
$4.9M
Q2 24
$12.1M
$14.1M
Q1 24
$10.2M
Net Profit
APYX
APYX
WPRT
WPRT
Q4 25
$-1.3M
Q3 25
$-2.0M
Q2 25
$-3.8M
$-34.3M
Q1 25
$-4.2M
Q4 24
$-4.6M
Q3 24
$-4.7M
$-3.9M
Q2 24
$-6.6M
$5.8M
Q1 24
$-7.6M
Gross Margin
APYX
APYX
WPRT
WPRT
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
6.7%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
13.6%
Q2 24
61.7%
16.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
WPRT
WPRT
Q4 25
0.1%
Q3 25
-6.5%
Q2 25
-22.6%
-8.1%
Q1 25
-32.4%
Q4 24
-21.4%
Q3 24
-31.6%
-43.9%
Q2 24
-45.7%
-54.9%
Q1 24
-64.6%
Net Margin
APYX
APYX
WPRT
WPRT
Q4 25
-6.8%
Q3 25
-15.4%
Q2 25
-33.2%
-274.8%
Q1 25
-44.0%
Q4 24
-32.5%
Q3 24
-40.9%
-79.3%
Q2 24
-54.0%
41.2%
Q1 24
-74.0%
EPS (diluted)
APYX
APYX
WPRT
WPRT
Q4 25
Q3 25
Q2 25
$-1.98
Q1 25
Q4 24
Q3 24
$-0.22
Q2 24
$-0.19
$0.34
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
WPRT
WPRT
Cash + ST InvestmentsLiquidity on hand
$31.7M
$6.1M
Total DebtLower is stronger
$37.5M
$977.0K
Stockholders' EquityBook value
$14.5M
$108.9M
Total Assets
$66.8M
$272.1M
Debt / EquityLower = less leverage
2.58×
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
WPRT
WPRT
Q4 25
$31.7M
Q3 25
$25.1M
Q2 25
$29.3M
$6.1M
Q1 25
$31.0M
Q4 24
$31.7M
Q3 24
$28.0M
Q2 24
$32.7M
Q1 24
$37.3M
Total Debt
APYX
APYX
WPRT
WPRT
Q4 25
$37.5M
Q3 25
$37.5M
Q2 25
$37.5M
$977.0K
Q1 25
$37.5M
Q4 24
$37.5M
Q3 24
$37.5M
Q2 24
Q1 24
Stockholders' Equity
APYX
APYX
WPRT
WPRT
Q4 25
$14.5M
Q3 25
$5.8M
Q2 25
$7.3M
$108.9M
Q1 25
$10.5M
Q4 24
$14.2M
Q3 24
$11.0M
$149.3M
Q2 24
$14.7M
$151.5M
Q1 24
$20.3M
Total Assets
APYX
APYX
WPRT
WPRT
Q4 25
$66.8M
Q3 25
$57.4M
Q2 25
$58.2M
$272.1M
Q1 25
$60.2M
Q4 24
$64.8M
Q3 24
$60.7M
Q2 24
$65.4M
Q1 24
$70.7M
Debt / Equity
APYX
APYX
WPRT
WPRT
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
0.01×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
WPRT
WPRT
Operating Cash FlowLast quarter
$-2.5M
$-5.6M
Free Cash FlowOCF − Capex
$-2.8M
$-6.4M
FCF MarginFCF / Revenue
-14.6%
-51.6%
Capex IntensityCapex / Revenue
1.4%
6.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
WPRT
WPRT
Q4 25
$-2.5M
Q3 25
$-3.5M
Q2 25
$-1.2M
$-5.6M
Q1 25
$-702.0K
Q4 24
$-2.9M
Q3 24
$-4.4M
$-11.7M
Q2 24
$-4.3M
$1.5M
Q1 24
$-6.3M
Free Cash Flow
APYX
APYX
WPRT
WPRT
Q4 25
$-2.8M
Q3 25
$-4.1M
Q2 25
$-1.5M
$-6.4M
Q1 25
$-757.0K
Q4 24
$-3.2M
Q3 24
$-4.6M
$-11.9M
Q2 24
$-4.6M
$262.0K
Q1 24
$-6.4M
FCF Margin
APYX
APYX
WPRT
WPRT
Q4 25
-14.6%
Q3 25
-31.5%
Q2 25
-13.2%
-51.6%
Q1 25
-8.0%
Q4 24
-22.4%
Q3 24
-40.0%
-243.4%
Q2 24
-38.0%
1.9%
Q1 24
-62.2%
Capex Intensity
APYX
APYX
WPRT
WPRT
Q4 25
1.4%
Q3 25
4.0%
Q2 25
2.3%
6.6%
Q1 25
0.6%
Q4 24
1.7%
Q3 24
1.3%
3.8%
Q2 24
2.4%
8.9%
Q1 24
0.3%
Cash Conversion
APYX
APYX
WPRT
WPRT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.26×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons